DOI: 10.1055/s-00000089

Ultraschall in der Medizin - European Journal of Ultrasound


Escudier B, Lassau N, Angevin E. et al.
Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma.

Clin Cancer Res 2007;
13: 1801-1809

Download Bibliographical Data

Search in: